Menu
Log in
HCM Society (logo)

   JOIN US

We work to enable HCM patients to live productive and fulfilling lives through clinical excellence, research,
and education. 
  

Warning: browser cookies disabled. Please enable them to use this website.

Select membership level

* Mandatory fields
* Membership level
  PODCAST

New on 11/18! A New Option for Young Patients: Inside the SCOUT-HCM Trial
Dr. Seema Mital, professor of pediatrics at the University of Toronto, head of cardiovascular research at The Hospital for Sick Children (SickKids), and senior author of the SCOUT-HCM trial, joins Dr. Betty Raman to discuss the trial’s findings on mavacamten in adolescents with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The conversation covers the treatment gaps facing children with HCM, why adolescents needed their own trial rather than extrapolated adult data, and results showing that nearly two thirds of patients on mavacamten became non-obstructive, with improvements in wall thickness, symptoms, peak VO2, and cardiac biomarkers. Dr. Mital also explains why the breathlessness questionnaire showed no clear difference, why no participants developed an ejection fraction below 50%, and how her site managed the burden of frequent echocardiogram monitoring for families. Additionally, the two weigh mavacamten against surgical myectomy for young patients, including considerations around pregnancy and lifelong treatment, and discuss the long-term data needed to determine whether cardiac myosin inhibitors are truly disease-modifying.  

Watch Here

PARTNERS


Showcase your commitment to advancing HCM research and education are while engaging directly with the clinicians and researchers driving innovation in diagnosis, treatment, and patient outcomes.

Details



Tel: (919) 573-1308, Fax: (919) 787-4916
Email: info@hcmsociety.org
3739 National Dr. Raleigh NC, 27612

Powered by Wild Apricot Membership Software